Practices should be evaluated for cytotoxic chemotherapy extravasation

the ONA take:

The influence of patient experience in health care is driving a review of practices to ensure it plays a part in developing clinical practice guidelines.

This literature review sought to analyze the quality of evidence that supports management practices of cytotoxic drug extravasation and determine if the patient experience is taken into account.

A literature search identified all studies on strategies aimed at preventing surgical debridement and all studies evaluating the patient’s perspective on extravasation management published from the 1960s to July 2014.

The researchers found no conclusive evidence that one clinical strategy is more effective than another, and no studies evaluated management strategies from the patient perspective.

The researchers suggest further outcomes-based studies are needed for extravasation management guidelines and how treatment impacts the patient.

In addition, they conclude that research into the patient experience of extravasation management needs to be addressed.

Study finds genetic variations associated with cisplatin-induced ototoxicity
This literature review sought to analyze the quality of evidence that supports management practices of cytotoxic drug extravasation.
Management of cytotoxic drug extravasation remains contentious, with differing views on the most effective management strategy. With the increasing drive to provide effective, evidence-based healthcare, while ensuring the patient experience of the treatment provided plays a significant part in the development of clinical practice guidelines, the purpose of this literature review was to both critically analyse the quality of evidence that underpins contemporary practice and to determine if the patient experience is taken into account.
READ FULL ARTICLE From Wiley Online Library
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs